| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 115.40 mm | 115.40 mm | 115.40 mm | 115.40 mm | 115.40 mm | 115.40 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 4.59 mm | (no burn) | 9.32 mm | 2.05 mm |
| Cash used (since last report) | n/a | n/a | 19.56 mm | n/a | 39.70 mm | 8.71 mm |
| Cash remaining | n/a | n/a | 95.84 mm | n/a | 75.69 mm | 106.69 mm |
| Runway (months of cash) | n/a | n/a | 20.9 | n/a | 8.1 | 52.2 |
| 13F holders | Current |
|---|---|
| Total holders | 129 |
| Opened positions | 21 |
| Closed positions | 19 |
| Increased positions | 37 |
| Reduced positions | 36 |
| 13F shares | Current |
|---|---|
| Total value | 198.50 bn |
| Total shares | 49.14 mm |
| Total puts | 34.60 k |
| Total calls | 39.70 k |
| Total put/call ratio | 0.9 |
| Largest owners | Shares | Value |
|---|---|---|
| NBIX Neurocrine Biosciences | 8.58 mm | $59.34 mm |
| BlackRock | 5.43 mm | $31.77 bn |
| Third Rock Ventures III | 5.43 mm | $0.00 |
| Armistice Capital | 5.20 mm | $30.42 bn |
| EcoR1 Capital | 3.92 mm | $22.92 bn |
| Vanguard | 3.19 mm | $18.64 bn |
| Farallon Capital Management | 2.29 mm | $13.41 bn |
| Dimensional Fund Advisors | 1.11 mm | $6.46 bn |
| Geode Capital Management | 1.08 mm | $6.32 bn |
| Erste Asset Management GmbH | 1.06 mm | $6.19 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Jan 25 | Todd Alfred Carter | Common Stock | Sell | Dispose S | No | No | 5.13 | 1,191 | 6.11 k | 86,436 |
| 14 Jan 25 | Robin Swartz | Common Stock | Sell | Dispose S | No | No | 5.09 | 3,087 | 15.71 k | 109,241 |
| 23 Dec 24 | Robin Swartz | Common Stock | Sell | Dispose S | No | No | 5.65 | 6,500 | 36.73 k | 112,328 |
| 2 Oct 24 | Sandell Jacquelyn Fahey | Common Stock | Sell | Dispose S | No | No | 5.82 | 5,999 | 34.91 k | 86,001 |
| 1 Oct 24 | Nathan D. Jorgensen | Common Stock | Grant | Acquire A | No | No | 0 | 80,000 | 0.00 | 80,000 |
